Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 5901 - 5925 of 6662 in total

4-[[(2S)-2-[[(2S)-3-Carboxy-2-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]butyl-(diaminomethylidene)azanium

Experimental

(5R,6S,8S)-8-[3-(AMINOMETHYL)PHENYL]-6-HYDROXY-5-ISOPROPYL-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE

Experimental

Vonlerolizumab

Vonlerolizumab is under investigation in clinical trial NCT03029832 (A Study of MOXR0916 in Combination With Atezolizumab Versus Atezolizumab Alone in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma Who Are Ineligible for Cisplatin-based Therapy).
Investigational

Oleylphosphocholine

Investigational

LAS-191954

Investigational

p-Toluenesulfonic acid

Experimental

Tuspetinib

Tuspetinib (HM-43239) is under investigation in clinical trial NCT03850574 (Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM43239 in Patients With Relapsed or Refractory Acute Myeloid Leukemia).
Investigational

N-[(2S,3S)-4-[2-[(5S)-3a,4,5,6,7,7a-Hexahydro-1,3-benzodioxol-5-yl]ethyl-[3-(1,3-dioxoisoindol-2-yl)propanoyl]amino]-3-hydroxy-1-phenylbutan-2-yl]-3,5-dimethoxy-4-phenylmethoxybenzamide

Experimental

N-(Sulfanylacetyl)Tyrosylprolylmethioninamide

Experimental

4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide

Experimental

5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine

Experimental

Methyl(6s)-1-Thio-L-Manno-Hexodialdo-6,2-Pyranoside

Experimental

N-[(6-butoxynaphthalen-2-yl)sulfonyl]-D-glutamic acid

Experimental

2-AMINO-6-(3,5-DIMETHYLPHENYL)SULFONYLBENZONITRILE

Experimental

(1S)-1-Phenylethyl (4-acetamidobenzyl)phosphonate

Experimental

(4S)-5-[[(2S)-1-[[(2S)-1-Amino-3-[4-[difluoro(phosphono)methyl]phenyl]-1-oxopropan-2-yl]amino]-3-[4-[difluoro(phosphono)methyl]phenyl]-1-oxopropan-2-yl]amino]-4-benzamido-5-oxopentanoic acid

Experimental

Laquinimod

Laquinimod is an immunomodulator developed by Active Biotech and produced by Teva Pharmaceutical Industries. It is currently under development in phase III trials for treatment of multiple sclerosis as an oral therapy, like fingolimod. It has been shown to reduce disease activity on magnetic resonance imaging and to be well...
Investigational

Lometrexol

Lometrexol has been used in trials studying the treatment of Lung Cancer, Drug/Agent Toxicity by Tissue/Organ, and Unspecified Adult Solid Tumor, Protocol Specific.
Investigational

Cefodizime

Experimental

Carpropamide

Experimental

L-tyrosinamide

Experimental

3-nitro-L-tyrosine

Experimental

Alfimeprase

Alfimeprase is a recombinant analog of fibrolase. Fibrolase is a zinc-containing metalloproteinase isolated from the venom of the southern copperhead snake (Agkistrodon contortrix contortrix). It is a small protein that contains 203 residues (Randolph et al. 1992). Alfimeprase is being developed by Nuvelo.
Investigational

Ergothioneine

Investigational

Mubodina

Mubodina is an investigational drug developed by Adienne Pharma & Biotech. It is a recombinant human minibody directed against complement component C5. It was investigated in various conditions including primary membranoproliferative glomerulonephritis and typical hemolytic uremic syndrome.
Investigational
Displaying drugs 5901 - 5925 of 6662 in total